Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "G-IVF and Sperm Parameters," is designed to explore whether adding a specific solution to a fresh sperm sample can improve the characteristics of the sperm. This research is important for men facing infertility issues, as better sperm quality can enhance the chances of successful conception.
To participate in this trial, men aged between 18 and 45 who can provide a sperm sample at the clinic may be eligible. However, individuals with a medical condition called azoospermia (where no sperm is present in the semen) or those who have had a vasectomy (a surgical procedure for birth control) will not be included. While the trial is not yet recruiting participants, those who do take part can expect to provide a semen sample and have it evaluated to see if the added solution makes a difference in sperm quality.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Patients producing a pre-clinical semen sample at the clinic
- Exclusion Criteria:
- • Patients with known azoospermia
- • Patients who have had a vasectomy
About Vitrolife
Vitrolife is a leading global company dedicated to advancing reproductive medicine and improving outcomes in assisted reproduction. With a strong focus on innovation and quality, Vitrolife develops and provides a comprehensive range of products and services, including culture media, cryopreservation solutions, and laboratory equipment, aimed at enhancing the efficiency and effectiveness of fertility treatments. Committed to supporting healthcare professionals and patients alike, Vitrolife actively engages in clinical research and trials to ensure the continuous improvement of reproductive technologies and to foster successful reproductive outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maroussi, , Greece
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials